FDA’s “Paperless” System Should Accommodate Variability Of Devices
This article was originally published in The Gray Sheet
Executive Summary
A "paperless" premarket submissions system for medical devices must be more flexible than the system for drugs, an AGA Medical executive told a panel of FDA and National Institutes of Health officials Dec. 18
You may also be interested in...
FDA Hears Experience Of Regional Device Safety Registries
FDA is soliciting ideas from regional programs that gather postmarket data to help design its proposed "Sentinel Network" for medical product safety information
FDA Hears Experience Of Regional Device Safety Registries
FDA is soliciting ideas from regional programs that gather postmarket data to help design its proposed "Sentinel Network" for medical product safety information
CDRH Unveils Postmarket Safety “Action Items”
FDA's plan to strengthen postmarket device safety by making better use of postmarket data includes modifying its organizational infrastructure, updating adverse event reporting practices and potentially increasing the use of fines for certain types of industry noncompliance